Vestmark Advisory Solutions’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-31,536
Closed -$252K 589
2020
Q3
$252K Buy
+31,536
New +$252K 0.03% 474